Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis

NCT06414954 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Myasthenia Gravis
Myasthenia Gravis, MuSK

Interventions

DRUG: NMD670
DRUG: Placebo

Sponsor

NMD Pharma A/S